Related Experiment Video
Updated: Jul 4, 2026
04:51
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
Published on: April 11, 2019
Falls associated with electroconvulsive therapy among the geriatric population: a case report
Sanjay S Rao1, John W Daly, Daniel D Sewell
1Department of Psychiatry, University of California, San Diego, CA, USA.
The Journal of ECT
|June 27, 2008
Summary
Electroconvulsive therapy (ECT) may be associated with an increased risk of falls in older adults. This case report suggests a potential link, emphasizing the need for further research into fall prevention during ECT treatment.
Area of Science:
- Geriatric Psychiatry
- Neurology
- Clinical Medicine
Background:
- Electroconvulsive therapy (ECT) is a primary treatment for severe depression in older adults.
- Potential risks of ECT include anesthesia complications and memory loss.
- The association between ECT and falls remains understudied.
Observation:
- A case study involving an elderly woman with recurrent major depressive disorder undergoing ECT.
- The patient experienced two falls during her ECT treatment course.
- This observation aligns with existing anecdotal evidence.
Findings:
- The case suggests a potential link between ECT and falls in the elderly.
- Existing literature primarily consists of case reports and chart reviews.
- More rigorous scientific data is needed to confirm this association.
Implications:
- Highlights the need for fall risk assessment and prevention strategies in patients receiving ECT.
- Calls for further research to establish causality and understand mechanisms.
- Informs clinical practice regarding patient safety during ECT for geriatric populations.
Related Concept Videos
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...